2024-09-02 - Analysis Report
##  MRK Stock Analysis

**Company Overview:**  MRK (Merck & Co., Inc.) is a global pharmaceutical company that develops, manufactures, and markets a wide range of prescription medications, vaccines, and animal health products. 

**Performance Analysis:**

1. **Relative Performance:** 
    * **Trailing Return:** MRK has a trailing return of 52.93%, while the S&P 500 (VOO) has a trailing return of 89.66%.
    * **Relative Performance:** MRK is currently lagging behind the S&P 500 by -36.73% with a relative performance rank of 38.25%. This means MRK's performance is currently in the 38.25th percentile of its historical performance relative to the S&P 500. 

2. **Recent Price Action:**
    * **Closing Price:** $118.45
    * **Moving Averages:**  5-Day MA: $117.22, 20-Day MA: $114.88, 60-Day MA: $122.73

    The recent price action shows a short-term uptrend as the current price is above the 5-day and 20-day moving averages. However, the price is below the 60-day moving average, indicating potential for further downward correction.

3. **Technical Indicators:**
    * **RSI:** 81.9 - This indicates the stock is in overbought territory, potentially suggesting a pullback could be on the horizon.
    * **PPO:** 0.74 -  This indicates a strong bullish momentum, suggesting further price appreciation is possible.
    * **Delta_Previous_Relative_Divergence:** -6.71 -  This suggests a recent downward shift in the stock's relative performance.
    * **Expected_Return:** 11.87% - This indicates the potential for a 11.87% return on investment over the next five years. 

4. **Recent Earnings & Outlook:** 

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-05 | 2.15 | $16.11B |
| 2024-05-03 | 1.88 | $15.78B |
| 2023-11-03 | 1.87 | $15.96B |
| 2023-08-07 | -2.35 | $15.04B |
| 2024-08-05 | -2.35 | $15.04B |

Most recent earnings (2024-08-05) reported an EPS of 2.15, exceeding analyst expectations of 1.98. Revenue of $16.11B also surpassed analyst estimates of $15.8B.

**Overall Analysis:**

MRK is currently in an overbought territory with strong bullish momentum. The recent earnings report was positive, beating analyst expectations. However, it is lagging behind the S&P 500 in terms of performance. The stock is currently experiencing a short-term uptrend, but is below its 60-day moving average, suggesting potential for further downward correction.  Overall, MRK is a strong company with a positive outlook, but investors should be mindful of the potential for a pullback given its overbought conditions.
